
Coral Genomics
AcquiredNew clinical tests for managing autoimmune treatments.
San Francisco, United States · Founded 2018 · $2.1M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- coralgenomics.com
- Total Funding
- $2.1M
About
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
Summary
Coral Genomics is a Genomics company based in San Francisco, United States, founded in 2018. It has raised $2.1M in total.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company